Research into keratoconus and eyecare equity in Aotearoa by the University of Auckland’s (UoA’s) Department of Ophthalmology has been bolstered by a significant award and three new fellowships. In S
Qlosi, Orasis Pharmaceuticals’ preservative-free 0.4% pilocarpine formulation, has received US Food and Drug Administration (FDA) approval for the treatment of presbyopia in adults. The company’s ph
A US study has shown optometrist-performed Nd:YAG laser capsulotomies to be safe and effective.
The first fully, immediately sequential, bilateral-cataract surgery (ISBCS) theatre list in the UK was completed at the start of November at the Nightingale Hospital in Exeter by Dr Harry Roberts.
Standing out from more than 1,490 in-person delegates (with a further 240 tuning in online) at this year’s RANZCO Congress in Perth were the 2023 new graduating fellows and many award winners.
US researchers have developed a technique to ‘guide’ blood-derived stem cells to mouse retinas to replace retinal ganglion cells (RGCs) lost to glaucoma. Donor stem cells injected into the eye
A recent study found Nova Eye Medical’s iTrack ab-interno canaloplasty microcatheter significantly reduced intraocular pressure (IOP) and medication requirements for patients with primary open-angle g
A Vietnamese study has shown how non-ophthalmic healthcare workers could detect signs of glaucoma from retinal images with an accuracy comparable with ophthalmologists after completing a short online
Moorfields has announced it will explore a possible new treatment for retinal detachment surgery complicated by scar tissue from proliferative vitreoretinopathy (PVR), the most common cause of retinal
A UK study found that since Black and South Asian diabetics were more likely to develop sight-threatening diabetic retinopathy (STDR), standard biennial screening would have delayed detection of some
LINKS: https://nzoptics.co.nz/articles/archive/red-light-therapy-for-myopia-control/In response to a young patient of Chinese ethnicity developing temporary vision loss and recoverable retinal damage
After more than five years and four applications, Southern Cross has added minimally invasive glaucoma surgery devices to its members’ policies...
